pioglitazone has been researched along with 3-nitrotyrosine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beal, MF; Calingasan, NY; Chen, J; Kiaei, M; Kipiani, K | 1 |
| Itoh, Y; Mori, Y; Obata, T; Tajima, N | 1 |
| Haruna, Y; Kashihara, N; Kobayashi, S; Komai, N; Namikoshi, T; Sasaki, T; Satoh, M; Tomita, N | 1 |
| Akasaka, T; Goto, M; Ikejima, H; Imanishi, T; Kobayashi, K; Kuroi, A; Mochizuki, S; Yoshida, K | 1 |
| Akasaka, T; Goto, M; Ikejima, H; Imanishi, T; Kuroi, A; Mochizuki, S; Muragaki, Y; Tsujioka, H; Yoshida, K | 1 |
| Gumieniczek, A; Krzywdzińska, M; Nowak, M | 1 |
| Kagota, S; Kunitomo, M; Nakamura, K; Nejime, N; Shinozuka, K; Tada, Y | 1 |
| Kong, X; Li, FX; Su, Q; Wu, HB; Zhang, DY; Zhang, Y | 1 |
| Kong, X; Li, XY; Ma, MZ; Qin, L; Su, Q; Wang, GD; Zhang, DY; Zhang, Y | 1 |
1 trial(s) available for pioglitazone and 3-nitrotyrosine
| Article | Year |
|---|---|
Effects of pioglitazone vs glibenclamide on postprandial increases in glucose and triglyceride levels and on oxidative stress in Japanese patients with type 2 diabetes.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Female; Glyburide; Glycated Hemoglobin; Humans; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipoprotein Lipase; Male; Middle Aged; Oxidative Stress; Pioglitazone; Postprandial Period; Thiazolidinediones; Time Factors; Triglycerides; Tyrosine | 2006 |
8 other study(ies) available for pioglitazone and 3-nitrotyrosine
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis.
Topics: Administration, Oral; Amyotrophic Lateral Sclerosis; Animals; Cell Count; Disease Models, Animal; Disease Progression; Gliosis; Lumbosacral Region; Mice; Mice, Transgenic; Neurons; Neuroprotective Agents; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Pioglitazone; PPAR gamma; Psychomotor Performance; Spinal Cord; Superoxide Dismutase; Survival Rate; Thiazolidinediones; Tyrosine; Weight Loss | 2005 |
Pioglitazone ameliorates endothelial dysfunction in obese rats with nephropathy.
Topics: Animals; Endothelium, Vascular; Kidney Diseases; Kidney Glomerulus; Male; Metabolic Syndrome; NADPH Oxidases; Obesity; Pioglitazone; Polymerase Chain Reaction; Rats; Rats, Zucker; RNA, Messenger; Thiazolidinediones; Tyrosine; Vasodilation | 2007 |
Effects of pioglitazone on nitric oxide bioavailability measured using a catheter-type nitric oxide sensor in angiotensin II-infusion rabbit.
Topics: Acetylcholine; Angiotensin II; Animals; Biopterins; Biosensing Techniques; Blood Pressure; Calibration; Catheterization; Enzyme Inhibitors; Heart Rate; Hypoglycemic Agents; Immunohistochemistry; Male; Nitric Oxide; omega-N-Methylarginine; Pioglitazone; PPAR gamma; Rabbits; Thiazolidinediones; Tyrosine; Vasoconstrictor Agents; Vasodilator Agents | 2008 |
Effect of pioglitazone on nitroglycerin-induced impairment of nitric oxide bioavailability by a catheter-type nitric oxide sensor.
Topics: Acetylcholine; Animals; Biopterins; Calibration; Catheterization; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Hypoglycemic Agents; Male; Models, Animal; Nitric Oxide; Nitroglycerin; Pioglitazone; PPAR gamma; Rabbits; Thiazolidinediones; Tyrosine; Vasodilator Agents | 2008 |
Modulation of nitrosative/oxidative stress in the lung of hyperglycemic rabbits by two antidiabetics, pioglitazone and repaglinide.
Topics: Administration, Oral; Animals; Blood Glucose; Carbamates; Catalase; Diabetes Mellitus, Experimental; Glutathione; Glutathione Peroxidase; Hyperglycemia; Hypoglycemic Agents; Lipid Peroxidation; Lung; Male; Oxidative Stress; Pioglitazone; Piperidines; Rabbits; Reactive Nitrogen Species; Superoxide Dismutase; Thiazolidinediones; Tyrosine | 2009 |
Telmisartan provides protection against development of impaired vasodilation independently of metabolic effects in SHRSP.Z-Lepr(fa)/IzmDmcr rats with metabolic syndrome.
Topics: Acetylcholine; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood; Blood Glucose; Blood Pressure; Cholesterol; Crosses, Genetic; Guanylate Cyclase; Hypoglycemic Agents; Insulin; Male; Mesenteric Arteries; Metabolic Syndrome; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Nitroprusside; Phenylephrine; Pioglitazone; Rats; Rats, Inbred SHR; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Telmisartan; Thiazolidinediones; Triglycerides; Tyrosine; Vasoconstriction; Vasodilation | 2011 |
Combination therapy with losartan and pioglitazone additively reduces renal oxidative and nitrative stress induced by chronic high fat, sucrose, and sodium intake.
Topics: Animals; Body Weight; Diet, High-Fat; Dietary Sucrose; Drug Synergism; Drug Therapy, Combination; Gene Expression Regulation, Enzymologic; Immunohistochemistry; Kidney; Losartan; Male; Malondialdehyde; NADPH Oxidases; Nitrosation; Oxidation-Reduction; Oxidative Stress; Pioglitazone; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium, Dietary; Superoxide Dismutase; Thiazolidinediones; Tyrosine | 2012 |
Pioglitazone enhances the blood pressure-lowering effect of losartan via synergistic attenuation of angiotensin II-induced vasoconstriction.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Blood Pressure; Drug Synergism; Endothelium, Vascular; Losartan; Male; NADPH Oxidases; Nitric Oxide Synthase Type III; Nitroprusside; Phenylephrine; Pioglitazone; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Systole; Thiazolidinediones; Tyrosine; Vasoconstriction; Vasodilation | 2014 |